{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:25:09Z","timestamp":1795166709369,"version":"4.10.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Abbott Diabetes Care (Sao Paulo, Brazil)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01854-x","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T04:11:22Z","timestamp":1754712682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Continuous glucose monitoring system in diabetes in pregnancy: a narrative review"],"prefix":"10.1186","volume":"17","author":[{"given":"Melanie","family":"Rodacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Krakauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Reis","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Medici","family":"Dualib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Sancovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenita","family":"Zajdenverg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"1854_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium. Access. March 2025, https:\/\/www.diabetesatlas.org (2021)."},{"key":"1854_CR2","doi-asserted-by":"publisher","first-page":"109049","DOI":"10.1016\/j.diabres.2021.109049","volume":"183","author":"T Chivese","year":"2022","unstructured":"Chivese T, Hoegfeldt CA, Werfalli M, Yuen L, Sun H, Karuranga S, et al. IDF diabetes atlas: the prevalence of pre-existing diabetes in pregnancy - A systematic review and meta-analysis of studies published during 2010\u20132020. Diabetes Res Clin Pract. 2022;183:109049. https:\/\/doi.org\/10.1016\/j.diabres.2021.109049.","journal-title":"Diabetes Res Clin Pract"},{"key":"1854_CR3","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes\u20142025. Diabetes Care. 2024; 48: S306-S320. https:\/\/doi.org\/10.2337\/dc25-S015","DOI":"10.2337\/dc25-S015"},{"key":"1854_CR4","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1016\/s2214-109x(20)30046-2","volume":"8","author":"B Voaklander","year":"2020","unstructured":"Voaklander B, Rowe S, Sanni O, Campbell S, Eurich D, Ospina MB. Prevalence of diabetes in pregnancy among Indigenous women in australia, canada, new zealand, and the USA: a systematic review and meta-analysis. Lancet Glob Health. 2020;8:e681\u201398. https:\/\/doi.org\/10.1016\/s2214-109x(20)30046-2.","journal-title":"Lancet Glob Health"},{"key":"1854_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3803\/EnM.2023.1805","volume":"38","author":"JH Yoo","year":"2023","unstructured":"Yoo JH, Kim JH. The benefits of continuous glucose monitoring in pregnancy. Endocrinol Metab (Seoul). 2023;38:472\u201381. https:\/\/doi.org\/10.3803\/EnM.2023.1805.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1854_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajog.2024.11.026","volume":"232","author":"NS Clement","year":"2025","unstructured":"Clement NS, Abul A, Farrelly R, Murphy HR, Forbes K, Simpson NAB, et al. Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025;232:354\u201366. https:\/\/doi.org\/10.1016\/j.ajog.2024.11.026.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"1854_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11892-017-0943-7","volume":"17","author":"J Immanuel","year":"2017","unstructured":"Immanuel J, Simmons D. Screening and treatment for Early-Onset gestational diabetes mellitus: a systematic review and Meta-analysis. Curr Diab Rep. 2017;17(11):115. https:\/\/doi.org\/10.1007\/s11892-017-0943-7.","journal-title":"Curr Diab Rep"},{"key":"1854_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2337\/dci20-0055","volume":"44","author":"D Simmons","year":"2021","unstructured":"Simmons D. Paradigm shifts in the management of diabetes in pregnancy: the importance of type 2 diabetes and early hyperglycemia in pregnancy: the 2020 Norbert Freinkel award lecture. Diabetes Care. 2021;44:1075\u201381. https:\/\/doi.org\/10.2337\/dci20-0055.","journal-title":"Diabetes Care"},{"key":"1854_CR9","doi-asserted-by":"publisher","DOI":"10.29327\/557753.2022-12","author":"L Zajdenverg","year":"2022","unstructured":"Zajdenverg L, Fa\u00e7anha C, Dualib P, Golbert A, Negrato CA. Planejamento, Metas e monitoriza\u00e7\u00e3o do diabetes Durante a gesta\u00e7\u00e3o. Diretriz Oficial Da Sociedade Brasileira De Diabetes. 2022. https:\/\/doi.org\/10.29327\/557753.2022-12.","journal-title":"Diretriz Oficial Da Sociedade Brasileira De Diabetes"},{"key":"1854_CR10","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes\u20142025. Diabetes Care. 2024; 48: S146-S166. https:\/\/doi.org\/10.2337\/dc25-S007","DOI":"10.2337\/dc25-S007"},{"key":"1854_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/AOG.0000000000005374","volume":"143","author":"R Horgan","year":"2024","unstructured":"Horgan R, Hage Diab Y, Fishel Bartal M, Sibai BM, Saade G. Continuous glucose monitoring in pregnancy. Obstet Gynecol. 2024;143:195\u2013203.","journal-title":"Obstet Gynecol"},{"key":"1854_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/dom.14962","volume":"25","author":"JS Pemberton","year":"2023","unstructured":"Pemberton JS, Wilmot EG, Barnard-Kelly K, Leelarathna L, Oliver N, Randell T, et al. CGM accuracy: contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes Obes Metab. 2023;25:916\u201339. https:\/\/doi.org\/10.1111\/dom.14962.","journal-title":"Diabetes Obes Metab"},{"key":"1854_CR13","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2337\/dc18-1150","volume":"41","author":"SV Edelman","year":"2018","unstructured":"Edelman SV, Argento NB, Pettus J, Hirsch IB. Clinical implications of Real-time and intermittently scanned continuous glucose monitoring. Diabetes Care. 2018;41:2265\u201374. https:\/\/doi.org\/10.2337\/dc18-1150.","journal-title":"Diabetes Care"},{"issue":"20230820","key":"1854_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1177\/19322968231190941","volume":"17","author":"G Freckmann","year":"2023","unstructured":"Freckmann G, Eichenlaub M, Waldenmaier D, Pleus S, Wehrstedt S, Haug C, et al. Clinical performance evaluation of continuous glucose monitoring systems: A scoping review and recommendations for reporting. J Diabetes Sci Technol. 2023;17(20230820):1506\u201326. https:\/\/doi.org\/10.1177\/19322968231190941.","journal-title":"J Diabetes Sci Technol"},{"issue":"20190619","key":"1854_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/1932296819855670","volume":"14","author":"L Heinemann","year":"2020","unstructured":"Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, Hinzmann R, Kassab A, Freckmann G, et al. Benefits and limitations of MARD as a performance parameter for continuous glucose monitoring in the interstitial space. J Diabetes Sci Technol. 2020;14(20190619):135\u201350. https:\/\/doi.org\/10.1177\/1932296819855670.","journal-title":"J Diabetes Sci Technol"},{"key":"1854_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/dom.16153","volume":"27","author":"C Mathieu","year":"2025","unstructured":"Mathieu C, Irace C, Wilmot EG, Akra B, Del Prato S, Cuesta M, et al. Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-\u2018eCGM\u2019 compliance status. Diabetes Obes Metab. 2025;27:1025\u2013103120241226. https:\/\/doi.org\/10.1111\/dom.16153.","journal-title":"Diabetes Obes Metab"},{"key":"1854_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/dia.2023.0435","volume":"26","author":"RA Vigersky","year":"2024","unstructured":"Vigersky RA, Shin J. The myth of MARD (Mean absolute relative Difference): Limitations of MARD in the Clinical Assessment of Continuous Glucose Monitoring Data. Diabetes Technol Ther. 2024;26:38\u201344. https:\/\/doi.org\/10.1089\/dia.2023.0435.","journal-title":"Diabetes Technol Ther"},{"key":"1854_CR18","doi-asserted-by":"publisher","unstructured":"Bailey TS, Alva S. Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations. Diabetes Technology & Therapeutics. 2021; 23: S-5-S-11. https:\/\/doi.org\/10.1089\/dia.2021.0236","DOI":"10.1089\/dia.2021.0236"},{"key":"1854_CR19","doi-asserted-by":"publisher","first-page":"193229682412503","DOI":"10.1177\/19322968241250357","volume":"0","author":"DC Klonoff","year":"2024","unstructured":"Klonoff DC, Gabbay M, Moon SJ, Wilmot EG. Importance of FDA-Integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring. J Diabetes Sci Technol. 2024;0:19322968241250357. https:\/\/doi.org\/10.1177\/19322968241250357.","journal-title":"J Diabetes Sci Technol"},{"key":"1854_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/dia.2020.0085","volume":"22","author":"K Castorino","year":"2020","unstructured":"Castorino K, Polsky S, O\u2019Malley G, Levister C, Nelson K, Farfan C, et al. Performance of the Dexcom G6 continuous glucose monitoring system in pregnant women with diabetes. Diabetes Technol Ther. 2020;22:943\u20137. https:\/\/doi.org\/10.1089\/dia.2020.0085.","journal-title":"Diabetes Technol Ther"},{"key":"1854_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/dia.2017.0386","volume":"20","author":"EM Scott","year":"2018","unstructured":"Scott EM, Bilous RW, Kautzky-Willer A, Accuracy. User acceptability, and safety evaluation for the freestyle libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther. 2018;20:180\u20138. https:\/\/doi.org\/10.1089\/dia.2017.0386.","journal-title":"Diabetes Technol Ther"},{"key":"1854_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1932296820911471","volume":"14","author":"J Han","year":"2020","unstructured":"Han J, Heinemann L, Ginsberg BH, Alva S, Appel M, Bess S, et al. The YSI 2300 analyzer replacement meeting report. J Diabetes Sci Technol. 2020;14:679\u201386. https:\/\/doi.org\/10.1177\/1932296820911471.","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"1854_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/dom.16153","volume":"27","author":"C Mathieu","year":"2025","unstructured":"Mathieu C, Irace C, Wilmot EG, Akra B, Del Prato S, Cuesta M, Aet. Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-\u2018eCGM\u2019 compliance status. Diabetes Obes Metab. 2025;27(3):1025\u201331. https:\/\/doi.org\/10.1111\/dom.16153. REFERENCIA REPETIDA 17.","journal-title":"Diabetes Obes Metab"},{"key":"1854_CR24","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1001\/jama.2019.4981","volume":"321","author":"AS Alexopoulos","year":"2019","unstructured":"Alexopoulos AS, Blair R, Peters AL. Management of preexisting diabetes in pregnancy: A review. JAMA. 2019;321:1811\u20139. https:\/\/doi.org\/10.1001\/jama.2019.4981.","journal-title":"JAMA"},{"key":"1854_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/aog.0000000000005682","volume":"144","author":"AR Blankstein","year":"2024","unstructured":"Blankstein AR, Sigurdson SM, Frehlich L, Raizman Z, Donovan LE, Lemieux P, et al. Pre-existing diabetes and stillbirth or perinatal mortality: A systematic review and Meta-analysis. Obstet Gynecol. 2024;144:608\u201319. https:\/\/doi.org\/10.1097\/aog.0000000000005682.","journal-title":"Obstet Gynecol"},{"key":"1854_CR26","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390:2347\u201359. https:\/\/doi.org\/10.1016\/S0140-6736(17)32400-5.","journal-title":"Lancet"},{"key":"1854_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","volume":"62","author":"K Kristensen","year":"2019","unstructured":"Kristensen K, \u00d6gge LE, Sengpiel V, Kj\u00f6lhede K, Dotevall A, Elfvin A, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies. Diabetologia. 2019;62:1143\u201353. https:\/\/doi.org\/10.1007\/s00125-019-4850-0.","journal-title":"Diabetologia"},{"key":"1854_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/dia.2021.0109","volume":"23","author":"SK N\u00f8rgaard","year":"2021","unstructured":"N\u00f8rgaard SK, Mathiesen ER, N\u00f8rgaard K, Ringholm L. Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and Real-Time continuous glucose monitoring in pregnant women with type 1 diabetes. Diabetes Technol Ther. 2021;23:665\u201372. https:\/\/doi.org\/10.1089\/dia.2021.0109.","journal-title":"Diabetes Technol Ther"},{"key":"1854_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/dia.2023.0548","volume":"26","author":"V Gao","year":"2024","unstructured":"Gao V, Snell-Bergeon JK, Malecha E, Johnson CA, Polsky S. Clinical effectiveness of continuous glucose monitoring in pregnancies affected by type 1 diabetes. Diabetes Technol Ther. 2024;26:526\u201335. https:\/\/doi.org\/10.1089\/dia.2023.0548.","journal-title":"Diabetes Technol Ther"},{"issue":"20240513","key":"1854_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/17446651.2024.2354471","volume":"19","author":"AA Khan","year":"2024","unstructured":"Khan AA, Ata F, Alsharkawy N, Othman EMM, Hassan IM, Taha FAM, et al. A retrospective study comparing the results of continuous glucose monitoring to self-blood glucose monitoring for pregnant women with type 1 diabetes mellitus. Expert Rev Endocrinol Metab. 2024;19(20240513):429\u201335. https:\/\/doi.org\/10.1080\/17446651.2024.2354471.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1854_CR31","unstructured":"NHS Digital. National Pregnancy in Diabetes Audit 2021 and 2022 (01 January 2021 to 31 December 2022). Access, March. 2025, https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-pregnancy-in-diabetes-audit\/2022. (2023)."},{"key":"1854_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/19322968241239341","volume":"18","author":"ED Szmuilowicz","year":"2024","unstructured":"Szmuilowicz ED, Barbour L, Brown FM, Durnwald C, Feig DS, O\u2019Malley G, et al. Continuous glucose monitoring metrics for pregnancies complicated by diabetes: critical appraisal of current evidence. J Diabetes Sci Technol. 2024;18:819\u201334. https:\/\/doi.org\/10.1177\/19322968241239341.","journal-title":"J Diabetes Sci Technol"},{"key":"1854_CR33","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1002\/edm2.369","volume":"5","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Lin R, Hua X, Churilov L, Gaca MJ, James S, et al. A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes. Endocrinol Diabetes Metab. 2022;5:e369. https:\/\/doi.org\/10.1002\/edm2.369.","journal-title":"Endocrinol Diabetes Metab"},{"key":"1854_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/dme.14046","volume":"36","author":"HR Murphy","year":"2019","unstructured":"Murphy HR, Feig DS, Sanchez JJ, de Portu S, Sale A, CONCEPTT Collaborative Group. Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with type 1 diabetes. Diabet Med. 2019;36:1652\u2013165820190704. https:\/\/doi.org\/10.1111\/dme.14046.","journal-title":"Diabet Med"},{"key":"1854_CR35","doi-asserted-by":"publisher","unstructured":"DiStefano MJ, McQueen RB, Gao V, Klein MP, Snell-Bergeon JK, Polsky S. The cost of continuous glucose monitoring versus Self-Monitoring of blood glucose in type 1 diabetes pregnancies in the united states: A cost-Consequences analysis using Real-World evidence. Diabetes Technol Ther. 2024;20241219. https:\/\/doi.org\/10.1089\/dia.2024.0478.","DOI":"10.1089\/dia.2024.0478"},{"issue":"20220714","key":"1854_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/ajo.13581","volume":"63","author":"J Sekhon","year":"2023","unstructured":"Sekhon J, Graham D, Mehrotra C, Li I. Continuous glucose monitoring: A cost-effective tool to reduce pre-term birth rates in women with type one diabetes. Aust N Z J Obstet Gynaecol. 2023;63(20220714):146\u201353. https:\/\/doi.org\/10.1111\/ajo.13581.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"20240705","key":"1854_CR37","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00125-024-06216-2","volume":"67","author":"A McLean","year":"2024","unstructured":"McLean A, Maple-Brown L, Murphy HR. Technology advances in diabetes pregnancy: right technology, right person, right time. Diabetologia. 2024;67(20240705):2103\u201313. https:\/\/doi.org\/10.1007\/s00125-024-06216-2.","journal-title":"Diabetologia"},{"key":"1854_CR38","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.ajogmf.2023.100969","volume":"5","author":"G Wilkie","year":"2023","unstructured":"Wilkie G, Melnik V, Brainard L, Antonioli S, Baltich Nelson B, Leung K, et al. Continuous glucose monitor use in type 2 diabetes mellitus in pregnancy and perinatal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5:100969. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100969.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1854_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13098-021-00657-0","volume":"13","author":"SY Li","year":"2021","unstructured":"Li SY, Guo H, Zhang Y, Li P, Zhou P, Sun LR, et al. Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus. Diabetol Metab Syndr. 2021;13:39. https:\/\/doi.org\/10.1186\/s13098-021-00657-0.","journal-title":"Diabetol Metab Syndr"},{"key":"1854_CR40","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.2337\/dc12-2360","volume":"36","author":"AL Secher","year":"2013","unstructured":"Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013;36:1877\u201383. https:\/\/doi.org\/10.2337\/dc12-2360.","journal-title":"Diabetes Care"},{"key":"1854_CR41","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/dom.13310","volume":"20","author":"DN Voormolen","year":"2018","unstructured":"Voormolen DN, DeVries JH, Sanson RM, Heringa MP, de Valk HW, Kok M, et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes Obes Metab. 2018;20:1894\u2013902. https:\/\/doi.org\/10.1111\/dom.13310.","journal-title":"Diabetes Obes Metab"},{"key":"1854_CR42","doi-asserted-by":"publisher","unstructured":"Ye S, Shahid I, Yates CJ, Kevat D, Lee IL. Continuous glucose monitoring in pregnant women with pregestational type 2 diabetes: a narrative review. Obstet Med. 2024;1753495x241258668. https:\/\/doi.org\/10.1177\/1753495x241258668.","DOI":"10.1177\/1753495x241258668"},{"key":"1854_CR43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1764208","author":"G Bitar","year":"2023","unstructured":"Bitar G, Cornthwaite JA, Sadek S, Ghorayeb T, Daye N, Nazeer S, et al. Continuous glucose monitoring and time in range: association with adverse outcomes among people with type 2 or gestational diabetes mellitus. Am J Perinatol. 2023. https:\/\/doi.org\/10.1055\/s-0043-1764208.","journal-title":"Am J Perinatol"},{"key":"1854_CR44","doi-asserted-by":"publisher","unstructured":"Beriwal S, Re F, Gibson S. Acceptability of and satisfaction with continuous glucose monitoring in pregnant women with type 2 diabetes mellitus: A service improvement project. Obstetric Med. 2024;0. https:\/\/doi.org\/10.1177\/1753495X241233030.","DOI":"10.1177\/1753495X241233030"},{"key":"1854_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/19322968221124956","volume":"17","author":"A McLean","year":"2023","unstructured":"McLean A, Sinha A, Barr E, Maple-Brown L. Feasibility and acceptability of intermittently scanned continuous glucose monitoring for women with type 2 diabetes in pregnancy. J Diabetes Sci Technol. 2023;17:256\u201325820220919. https:\/\/doi.org\/10.1177\/19322968221124956.","journal-title":"J Diabetes Sci Technol"},{"key":"1854_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1479-828X.2007.00716.x","volume":"47","author":"K McLachlan","year":"2007","unstructured":"McLachlan K, Jenkins A, O\u2019Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol. 2007;47:186\u201390. https:\/\/doi.org\/10.1111\/j.1479-828X.2007.00716.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1854_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(24)00825-0","volume":"404","author":"A Sweeting","year":"2024","unstructured":"Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH, et al. Epidemiology and management of gestational diabetes. Lancet. 2024;404:175\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(24)00825-0.","journal-title":"Lancet"},{"issue":"20230510","key":"1854_CR48","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00592-023-02091-2","volume":"60","author":"A Majewska","year":"2023","unstructured":"Majewska A, Stanirowski PJ, Tatur J, Wojda B, Radosz I, Wielgos M, et al. Flash glucose monitoring in gestational diabetes mellitus (FLAMINGO): a randomised controlled trial. Acta Diabetol. 2023;60(20230510):1171\u20137. https:\/\/doi.org\/10.1007\/s00592-023-02091-2.","journal-title":"Acta Diabetol"},{"key":"1854_CR49","doi-asserted-by":"publisher","unstructured":"Lai M, Weng J, Yang J, Gong Y, Fang F, Li N et al. Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c\u2009<\u20096%: a randomized controlled trial. Frontiers in Endocrinology. 2023; 14. Original Research. https:\/\/doi.org\/10.3389\/fendo.2023.1174239","DOI":"10.3389\/fendo.2023.1174239"},{"key":"1854_CR50","doi-asserted-by":"publisher","first-page":"e14703","DOI":"10.1111\/dme.14703","volume":"39","author":"RM Garcia-Moreno","year":"2022","unstructured":"Garcia-Moreno RM, Benitez-Valderrama P, Barquiel B, Gonz\u00e1lez P\u00e9rez-de-Villar N, Hillman N, Lora Pablos D, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022;39:e14703. https:\/\/doi.org\/10.1111\/dme.14703.","journal-title":"Diabet Med"},{"key":"1854_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00592-021-01800-z","volume":"59","author":"W Hannah","year":"2022","unstructured":"Hannah W, Bhavadharini B, Beks H, Deepa M, Anjana RM, Uma R, et al. Global burden of early pregnancy gestational diabetes mellitus (eGDM): A systematic review. Acta Diabetol. 2022;59:403\u201342720211107. https:\/\/doi.org\/10.1007\/s00592-021-01800-z.","journal-title":"Acta Diabetol"},{"issue":"20230505","key":"1854_CR52","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","volume":"388","author":"D Simmons","year":"2023","unstructured":"Simmons D, Immanuel J, Hague WM, Teede H, Nolan CJ, Peek MJ, et al. Treatment of gestational diabetes mellitus diagnosed early in pregnancy. N Engl J Med. 2023;388(20230505):2132\u201344. https:\/\/doi.org\/10.1056\/NEJMoa2214956.","journal-title":"N Engl J Med"},{"issue":"20240620","key":"1854_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/s0140-6736(24)00827-4","volume":"404","author":"MF Hivert","year":"2024","unstructured":"Hivert MF, Backman H, Benhalima K, Catalano P, Desoye G, Immanuel J, et al. Pathophysiology from preconception, during pregnancy, and beyond. Lancet. 2024;404(20240620):158\u201374. https:\/\/doi.org\/10.1016\/s0140-6736(24)00827-4.","journal-title":"Lancet"},{"key":"1854_CR54","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2337\/dc23-2149","volume":"47","author":"C Durnwald","year":"2024","unstructured":"Durnwald C, Beck RW, Li Z, Norton E, Bergenstal RM, Johnson M, et al. Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. Diabetes Care. 2024;47:1333\u201341. https:\/\/doi.org\/10.2337\/dc23-2149.","journal-title":"Diabetes Care"},{"key":"1854_CR55","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.2337\/dc24-0944","volume":"47","author":"BSY Lim","year":"2024","unstructured":"Lim BSY, Yang Q, Choolani M, Gardner DSL, Chong YS, Zhang C, et al. Utilizing continuous glucose monitoring for early detection of gestational diabetes mellitus and pregnancy outcomes in an Asian population. Diabetes Care. 2024;47:1916\u201321. https:\/\/doi.org\/10.2337\/dc24-0944.","journal-title":"Diabetes Care"},{"key":"1854_CR56","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41574-019-0197-3","volume":"15","author":"L Ringholm","year":"2019","unstructured":"Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol. 2019;15:406\u201316.","journal-title":"Nat Rev Endocrinol"},{"issue":"20210525","key":"1854_CR57","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/dia.2021.0073","volume":"23","author":"D Tundidor","year":"2021","unstructured":"Tundidor D, Meek CL, Yamamoto J, Mart\u00ednez-Bru C, Gich I, Feig DS, et al. Continuous glucose monitoring Time-in-Range and HbA(1c) targets in pregnant women with type 1 diabetes. Diabetes Technol Ther. 2021;23(20210525):710\u20134. https:\/\/doi.org\/10.1089\/dia.2021.0073.","journal-title":"Diabetes Technol Ther"},{"key":"1854_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/dc23-0636","volume":"47","author":"AA Sanusi","year":"2024","unstructured":"Sanusi AA, Xue Y, McIlwraith C, Howard H, Brocato BE, Casey B, et al. Association of continuous glucose monitoring metrics with pregnancy outcomes in patients with preexisting diabetes. Diabetes Care. 2024;47:89\u201396. https:\/\/doi.org\/10.2337\/dc23-0636.","journal-title":"Diabetes Care"},{"key":"1854_CR59","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1089\/dia.2023.0300","volume":"25","author":"A McLean","year":"2023","unstructured":"McLean A, Barr E, Tabuai G, Murphy HR, Maple-Brown L. Continuous glucose monitoring metrics in High-Risk pregnant women with type 2 diabetes. Diabetes Technol Ther. 2023;25:836\u201344. https:\/\/doi.org\/10.1089\/dia.2023.0300.","journal-title":"Diabetes Technol Ther"},{"issue":"20240829","key":"1854_CR60","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/aog.0000000000005710","volume":"144","author":"LM Nally","year":"2024","unstructured":"Nally LM, Blanchette JE. Integrated strategies to support diabetes technology in pregnancy. Obstet Gynecol. 2024;144(20240829):599\u2013607. https:\/\/doi.org\/10.1097\/aog.0000000000005710.","journal-title":"Obstet Gynecol"},{"key":"1854_CR61","doi-asserted-by":"publisher","first-page":"e084216","DOI":"10.1136\/bmjopen-2024-084216","volume":"14","author":"The GO MOMs Study Group","year":"2024","unstructured":"The GO MOMs Study Group. Design, rationale, and protocol for glycemic observation and metabolic outcomes in mothers and offspring (GO MOMs): an observational cohort study. BMJ Open. 2024;14:e084216. https:\/\/doi.org\/10.1136\/bmjopen-2024-084216.","journal-title":"BMJ Open"},{"issue":"20230921","key":"1854_CR62","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1111\/dom.15276","volume":"25","author":"D Rademaker","year":"2023","unstructured":"Rademaker D, van der Wel AWT, van Eekelen R, Voormolen DN, de Valk HW, Evers IM, et al. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the glucomoms trial. Diabetes Obes Metab. 2023;25(20230921):3798\u2013806. https:\/\/doi.org\/10.1111\/dom.15276.","journal-title":"Diabetes Obes Metab"},{"key":"1854_CR63","doi-asserted-by":"publisher","unstructured":"Burk J, Ross GP, Hernandez TL, Colagiuri S, Sweeting A. Evidence for improved glucose metrics and perinatal outcomes with continuous glucose monitoring compared to self-monitoring in diabetes during pregnancy. Am J Obstet Gynecol. 2025:S0002-9378(25)00217-0. https:\/\/doi.org\/10.1016\/j.ajog.2025.04.010","DOI":"10.1016\/j.ajog.2025.04.010"},{"key":"1854_CR64","doi-asserted-by":"publisher","first-page":"20240510","DOI":"10.1136\/bmjdrc-2023-003989","volume":"12","author":"AL Carlson","year":"2024","unstructured":"Carlson AL, Beck RW, Li Z, Norton E, Bergenstal RM, Johnson M, et al. Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. BMJ Open Diabetes Res Care. 2024;12:20240510. https:\/\/doi.org\/10.1136\/bmjdrc-2023-003989.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"20190214","key":"1854_CR65","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/dc18-2212","volume":"42","author":"GR Law","year":"2019","unstructured":"Law GR, Alnaji A, Alrefaii L, Endersby D, Cartland SJ, Gilbey SG, et al. Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care. 2019;42(20190214):810\u20135. https:\/\/doi.org\/10.2337\/dc18-2212.","journal-title":"Diabetes Care"},{"key":"1854_CR66","doi-asserted-by":"publisher","first-page":"100823","DOI":"10.1016\/j.lanwpc.2023.100823","volume":"39","author":"X Liang","year":"2023","unstructured":"Liang X, Fu Y, Lu S, Shuai M, Miao Z, Gou W. Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study. Lancet Reg Health West Pac. 2023;39:100823. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100823.","journal-title":"Lancet Reg Health West Pac"},{"key":"1854_CR67","doi-asserted-by":"publisher","first-page":"e122121","DOI":"10.1016\/j.ajog.2024.03.026","volume":"231","author":"AN Battarbee","year":"2024","unstructured":"Battarbee AN, Sauer SM, Sanusi A, Fulcher I. Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes. Am J Obstet Gynecol. 2024;231:e122121\u2013122. https:\/\/doi.org\/10.1016\/j.ajog.2024.03.026.","journal-title":"Am J Obstet Gynecol"},{"key":"1854_CR68","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2337\/dc19-2527","volume":"43","author":"EM Scott","year":"2020","unstructured":"Scott EM, Feig DS, Murphy HR, Law GR, CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnancy: importance of analyzing Temporal profiles to understand clinical outcomes. Diabetes Care. 2020;43:1178\u201384. https:\/\/doi.org\/10.2337\/dc19-2527.","journal-title":"Diabetes Care"},{"key":"1854_CR69","unstructured":"Posicionamento Oficial, SBD 02\/2024. Posicionamento Da SBD sobre a utiliza\u00e7\u00e3o de alarmes Em sensores de glicose Para Pessoas com diabetes. Sociedade Brasileira de Diabetes; 2024."},{"key":"1854_CR70","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes\u20142024. Diabetes Care. 2023; 47: S282-S294. https:\/\/doi.org\/10.2337\/dc24-S015","DOI":"10.2337\/dc24-S015"},{"issue":"20190608","key":"1854_CR71","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(20190608):1593\u2013603. https:\/\/doi.org\/10.2337\/dci19-0028.","journal-title":"Diabetes Care"},{"key":"1854_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/aog.0000000000005669","volume":"144","author":"AN Battarbee","year":"2024","unstructured":"Battarbee AN, Durnwald C, Yee LM, Valent AM. Continuous glucose monitoring for diabetes management during pregnancy: evidence, practical tips, and common pitfalls. Obstet Gynecol. 2024;144:649\u201359. https:\/\/doi.org\/10.1097\/aog.0000000000005669.","journal-title":"Obstet Gynecol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01854-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:13:27Z","timestamp":1757358807000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01854-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01854-x","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: Melanie Rodacki has received support from Abbott, NovoNordisk, Sanofi.Marcio Krakauer has received support from Abbott, Novo Nordisk, Lilly, Astra, Roche, Medtronic, Boehringer Ingelheim, EMS, Servier.Denise Reis Franco has received support from Abbott, Lilly, Novo Nordisk, Sanofi, Medtronic.Patricia Medici Dualib declares no conflicts of interest.Mauro Sancovski declares no conflicts of interest.Lenita Zajdenverg has been consultant for Novonordisk and EMS; and speaker for NovoNordisk and Chiesi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}